- Filter by topic
- Filter by topic
- All Topics
- Alzheimer's Disease
- Environmental, Social & Governance (ESG)
- Living with...
- Multiple Sclerosis (MS)
- People & Culture
- Pioneering Science
- Science & Innovation
- Spinal Muscular Atrophy (SMA)
Scott’s story: Living with Alzheimer’s disease Scott’s story: Living with Alzheimer’s disease When Scott was 59 years old, he and his wife Jill began noticing some changes in his cognition. Scott was struggling to find the right words in conversations and was having difficulties problem solving and remembering names. Three years after he first experienced symptoms, Scott was diagnosed with Alzheimer's dementia.
The Economic and Societal Cost of Alzheimer's Disease in Australia, 2021-2041 Report The Economic and Societal Cost of Alzheimer's Disease in Australia, 2021-2041 Report A new report from the University of Canberra’s National Centre for Social and Economic Modelling (NATSEM) reveals the staggering future economic cost of Alzheimer's disease, and its impact on Australia’s workforce, patients, families and communities. This report expands on NATSEM and Dementia Australia’s Economic Cost of Dementia in Australia 2016-2056 Report released in 2017 and projects a 20-year $442 billion impact to the Australian economy.
The Future of Alzheimer’s disease White Paper The Future of Alzheimer’s disease White Paper As the most common form of dementia, AD currently affects approximately 330,000 Australians and is a major cause of death and disability. There is a window of opportunity in Australia to prepare for the potential introduction of disease-modifying therapies (DMTs) for this devastating disease.
Happy Birthday, Biogen Australia and New Zealand Happy Birthday, Biogen Australia and New Zealand After 20 years in Australia and 15 in New Zealand, Biogen remains steadfast in its commitment to work fearlessly to change lives. Biogen Australia and New Zealand is proud to have highly motivated and engaged people with a strong commitment to patients. A strong culture of inclusion and diversity empowers Biogen’s people to make a positive impact on the communities they serve.
Where Science Meets Humanity Stephen’s story: Living with Multiple Sclerosis Stephen was 22 years old when he was diagnosed with Multiple Sclerosis (MS), a life-long autoimmune disease that damages the central nervous system (CNS). Over time, damage to the CNS can cause physical disability and impair neurological functions like motor skills, thinking and vision.